Korsana Biosciences, Inc. (KRSA)

32.79 +1.68 (+5.40%) USD  |  NASDAQ  |  Nov 11, 13:35
More

Korsana Biosciences Total Expenses (% of Annual Revenues)

Total Expenses (% of Annual Revenues) Chart

View Total Expenses (% of Annual Revenues) for KRSA.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00

Historical Total Expenses (% of Annual Revenues) Data

View and export this data back to 2019. Start Trial.
Date Value
December 31, 2025 --
December 31, 2024 --
December 31, 2022 --
Date Value
December 31, 2021 --
December 31, 2020 --
December 31, 2019 --

Total Expenses (% of Annual Revenues) Range, Past 5 Years

View Total Expenses (% of Annual Revenues) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Expenses (% of Annual Revenues) Benchmarks

View Total Expenses (% of Annual Revenues) Benchmarks
Start Trial
Q32 Bio, Inc. Upgrade
IRulya Therapeutics, Inc. --
Climb Bio, Inc. --
PepGen Inc. --
Bridgebio Oncology Therapeutics, Inc. --